Research Square
A Phase 2b randomized clinical trial of the oral p38α inhibitor neflamapimod in dementia with Lewy bodies (DLB)
Preprint: trial in peopleInterventions
Papers by Niels D. Prins
3 results
- AAIC 2025 Abstract
Women are less likely to be eligible for AD trials than men.
Study in peoplePopulations